Citius Oncology, Inc (CTOR) - Yalpi marja

CTOR (Citius Oncology, Inc) - kompaniyaning tovar belgisi

ESG standartlari va bioetikaning dori vositalarini ishlab chiqishga integratsiyalashuvi Citius Oncology, Inc. (CTOR) kompaniyasining ishonchliligini ta'minlaydi. Valo profit marjasi samaradorlik tendentsiyasini aniq tasdiqlaydi, bunda 28.90 parametrning joriy holatini belgilaydi. Maqsadli limfoma davolash usullari tufayli shifokorlarning ishonchi ortib bormoqda, garchi sotuvlarning yo'qligi va tashqi moliyalashtirishga bog'liqlik biznes uchun o'ziga xos moliyaviy inersiyani yaratayotgan bo'lsa-da.

CTOR citiusonc.com Yalpi foyda bo'yicha rentabellik (14.08.2024 - 20.11.2026)

Citius Oncology (CTOR) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Fundamental baholash:CTOR, Citius Oncology Inc.
citiusonc.com brend mahsuloti

Citius Oncology, Inc. (CTOR) kompaniyasining fundamental barqarorligini baholash uchun investorlar bevosita xarajatlarni boshqarish samaradorligini tahlil qilishlari kerak. Ushbu yalpi foyda marjasi sotilgan tovarlar tannarxini chegirib tashlagandan keyingi foyda ulushini o'lchaydi va beqarorlik sharoitida operatsion marjalarning tiklanish tezligini aks ettiradi. LYMPHIR ning yuqori ishlab chiqish xarajatlari va FDA ning qat'iy nazorati ushbu ko'rsatkichni proprietary aktivning tijorat jihatidan hayotiy ekanligini tasdiqlash uchun muhim qiladi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik